Clinical Trials Directory

Trials / Unknown

UnknownNCT04651972

Measurement of vanilloïd Compounds in Urin of Autistic vs Control Patients, as Potential Biomarkers

Diagnostic of Autism by Measurement of vanilloïd Compounds in Urin

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
Male
Age
2 Years – 14 Years
Healthy volunteers
Accepted

Summary

In a former study, four vanilloid compounds were observed increased in the urin of autistic patients. The present study is aimed at performing a ambispective study to confirm or not these preliminary results. 70 urins from autistic children (already collected) will be compared to 70 urins of non autistic children (collected without intervention, remaining sample from the standard care), in terms of measurements of four vanilloid compounds using a GCMS apparatus.

Conditions

Timeline

Start date
2020-12-15
Primary completion
2022-07-30
Completion
2022-07-30
First posted
2020-12-03
Last updated
2020-12-03

Source: ClinicalTrials.gov record NCT04651972. Inclusion in this directory is not an endorsement.